Results for tag: "Yondelis"

Yondelis (trabectedin) is an oncology drug used to treat certain types of cancer, including soft tissue sarcoma and ovarian cancer. It is a chemotherapy drug that works by interfering with the growth of cancer cells. Yondelis is administered intravenously and is usually given in combination with other chemotherapy drugs. It is approved for use in the United States, Europe, and other countries. Yondelis is a relatively new drug, having been approved in the United States in 2015. It is marketed by Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson. Yondelis is also available in generic form in some countries. The Yondelis market is a rapidly growing segment of the oncology drug market. It is expected to continue to grow as more patients are diagnosed with cancer and as new treatments become available. Some of the companies in the Yondelis market include Janssen Pharmaceuticals, Johnson & Johnson, Teva Pharmaceuticals, and Mylan Pharmaceuticals. Show Less Read more